Search research articles
Contact Us
Filters
Showing results (31-40 of 323) with videos related to
Page
of 33
Sort By:
JAMA
|
August 21, 2024
Surrogate Markers and Clinical Outcomes
Pascal Richette, Nicola Dalbeth, Lisa K Stamp
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 3, 2026
Revisiting the Ethics of Urate-Lowering Therapy Clinical Trials for Gout Management
Lisa K Stamp, Dien Ho, Nicola Dalbeth
Nature Reviews. Rheumatology
|
September 30, 2015
Allopurinol hypersensitivity: investigating the cause and minimizing the risk
Lisa K Stamp, Richard O Day, James Yun
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 24, 2024
Yet More Reassurance: Treat-to-Target With Allopurinol or Febuxostat is Safe and Effective in Lowering Serum Urate in People With CKD
Lisa K Stamp, Nicola Dalbeth, David B Mount
Rheumatology (Oxford, England)
|
December 15, 2020
What is remission in gout and how should we measure it?
Nicola Dalbeth, Lisa K Stamp, William J Taylor
BMC Medicine
|
June 2, 2017
The genetics of gout: towards personalised medicine?
Nicola Dalbeth, Lisa K Stamp, Tony R Merriman
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
March 9, 2012
Detection of allantoin in clinical samples using hydrophilic liquid chromatography with stable isotope dilution negative ion tandem mass spectrometry
Rufus Turner, Lisa K Stamp, Anthony J Kettle
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 21, 2025
The importance of considering the gout flare: let's learn to walk and chew gum at the same time in gout clinical trial design
Lisa K Stamp, Martin A Kennedy, Nicola Dalbeth
Internal Medicine Journal
|
April 24, 2024
Gout and its management
Nicola Dalbeth, Leanne Te Karu, Lisa K Stamp
Therapeutic Advances in Musculoskeletal Disease
|
July 15, 2021
Inequities in people with gout: a focus on Māori (Indigenous People) of Aotearoa New Zealand
Leanne Te Karu, Nicola Dalbeth, Lisa K Stamp
Page
of 33
Search research articles
Search
Showing results (31-40 of 323) with videos related to
Sort By:
Page
of 33
JAMA
|
August 21, 2024
Surrogate Markers and Clinical Outcomes
Pascal Richette, Nicola Dalbeth, Lisa K Stamp
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 3, 2026
Revisiting the Ethics of Urate-Lowering Therapy Clinical Trials for Gout Management
Lisa K Stamp, Dien Ho, Nicola Dalbeth
Nature Reviews. Rheumatology
|
September 30, 2015
Allopurinol hypersensitivity: investigating the cause and minimizing the risk
Lisa K Stamp, Richard O Day, James Yun
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 24, 2024
Yet More Reassurance: Treat-to-Target With Allopurinol or Febuxostat is Safe and Effective in Lowering Serum Urate in People With CKD
Lisa K Stamp, Nicola Dalbeth, David B Mount
Rheumatology (Oxford, England)
|
December 15, 2020
What is remission in gout and how should we measure it?
Nicola Dalbeth, Lisa K Stamp, William J Taylor
BMC Medicine
|
June 2, 2017
The genetics of gout: towards personalised medicine?
Nicola Dalbeth, Lisa K Stamp, Tony R Merriman
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
March 9, 2012
Detection of allantoin in clinical samples using hydrophilic liquid chromatography with stable isotope dilution negative ion tandem mass spectrometry
Rufus Turner, Lisa K Stamp, Anthony J Kettle
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 21, 2025
The importance of considering the gout flare: let's learn to walk and chew gum at the same time in gout clinical trial design
Lisa K Stamp, Martin A Kennedy, Nicola Dalbeth
Internal Medicine Journal
|
April 24, 2024
Gout and its management
Nicola Dalbeth, Leanne Te Karu, Lisa K Stamp
Therapeutic Advances in Musculoskeletal Disease
|
July 15, 2021
Inequities in people with gout: a focus on Māori (Indigenous People) of Aotearoa New Zealand
Leanne Te Karu, Nicola Dalbeth, Lisa K Stamp
Page
of 33